Literature DB >> 6712182

Encephalopathy following arteriography: a possible toxic effect of contrast agents.

E C Haley.   

Abstract

Three elderly men being evaluated for cerebrovascular disease developed acute confusional states following arteriography with approximately 50 ml of meglumine iothalamate. Two patients became stuporous. All recovered in several days, and no specific cause was found for the disorder. In the absence of other demonstrated abnormalities, we suggest that in each patient the encephalopathy may have been a toxic reaction to the contrast agent.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6712182     DOI: 10.1002/ana.410150118

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  4 in total

1.  Joint quality improvement guidelines for pediatric arterial access and arteriography: from the Societies of Interventional Radiology and Pediatric Radiology.

Authors:  Manraj K S Heran; Francis Marshalleck; Michael Temple; Clement J Grassi; Bairbre Connolly; Richard B Towbin; Kevin M Baskin; Josee Dubois; Mark J Hogan; Sanjoy Kundu; Donald L Miller; Derek J Roebuck; Steven C Rose; David Sacks; Manrita Sidhu; Michael J Wallace; Darryl A Zuckerman; John F Cardella
Journal:  Pediatr Radiol       Date:  2010-02

2.  Rapid contrast-induced encephalopathy after a small dose of contrast agent: illustrative case.

Authors:  Zhouyang Zhao; Lijin Huang; Jinhua Chen; Hongshen Zhu
Journal:  J Neurosurg Case Lessons       Date:  2021-01-04

3.  Contrast-Induced Encephalopathy after Percutaneous Coronary Intervention.

Authors:  Min-Tsun Liao; Tin-Tse Lin; Lian-Yu Lin; Juey-Jen Hwang; Chuen-Den Tseng
Journal:  Acta Cardiol Sin       Date:  2013-05       Impact factor: 2.672

4.  Dynamic Effects of Ioversol on the Permeability of the Blood-Brain Barrier and the Expression of ZO-1/Occludin in Rats.

Authors:  Heying Wang; Tao Li; Lili Zhao; Man Sun; Yating Jian; Jiao Liu; Yiheng Zhang; Ye Li; Meijuan Dang; Guilian Zhang
Journal:  J Mol Neurosci       Date:  2019-04-07       Impact factor: 3.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.